Industry Satellite Symposia | European Cystic Fibrosis Society (ECFS)

Thursday 9 June 2022 12:30–14:00 (CEST)	Advancing patient care in CF: Where next? Chair: Harm Tiddens (NL)
12:30 - 12:32	Introductory animation
12:32 – 12:42	Chair’s intro: CF management: Looking back to think ahead Q&A	Harm Tiddens Erasmus MC (NL)
12:42 - 12:57	CF today and tomorrow: Following the disease course Q&A	Peter Barry, Manchester University NHS Foundation Trust (UK)
12:57 - 13:12	Adherence in CF: What do we know? Q&A	Alexandra Quittner Behavioral Health Systems Research (US)
13:12 - 13:27	Patient outcomes: What counts and can be counted? Q&A	Barry Plant Cork University Hospital (IE)
13:27 - 13:57	Panel discussion and Q&A – a multidisciplinary perspective	All speakers plus Chris Smith, Brighton and Sussex University Hospitals (UK) and Inge Heeres, Erasmus MC (NL)
13.57 - 14:00	Chair’s close of symposium	Harm Tiddens Erasmus MC (NL)

Thursday 9 June 2022 19:00–20:30 (CEST)	Inhaled antibiotics in cystic fibrosis: Still a standard of care in the new normal? Chairs: Stuart Elborn (UK) / Stephanie Thee (DE)
Speakers	Professor J. Stuart Elborn, clinician, UK (co-chair) Dr. Stephanie Thee, clinician, DE (co-chair) Dr. Simone Gambazza, physiotherapist, IT Cora de Kiviet, nurse, NL
Agenda	An interactive on-stage discussion featuring multiple perspectives within cystic fibrosis Defining the "new normal" for inhaled antibiotics within cystic fibrosis as part of an evolving treatment landscape The treatment expectations placed on antibiotics and how these may be managed The challenges that patients with cystic fibrosis, nurses, physiotherapists and doctors face and different approaches to overcome them How patient health may be optimised and maintained through a hybrid treatment approach

Thursday 9 June 2022
19:00–20:30 (CEST)

Inhaled antibiotics in cystic fibrosis: Still a standard of care in the new normal?
Chairs: Stuart Elborn (UK) / Stephanie Thee (DE)

Speakers

Professor J. Stuart Elborn, clinician, UK (co-chair)
Dr. Stephanie Thee, clinician, DE (co-chair)
Dr. Simone Gambazza, physiotherapist, IT
Cora de Kiviet, nurse, NL

Agenda

An interactive on-stage discussion featuring multiple perspectives within cystic fibrosis

Defining the "new normal" for inhaled antibiotics within cystic fibrosis as part of an evolving treatment landscape
The treatment expectations placed on antibiotics and how these may be managed
The challenges that patients with cystic fibrosis, nurses, physiotherapists and doctors face
and different approaches to overcome them
How patient health may be optimised and maintained through a hybrid treatment approach

Friday 10 June 2022 12:30–14:00 (CEST)	Continuing the journey of innovation for all people with CF Chair: Stuart Elborn (UK)
12:30 - 12:32	Introductory animation
12:32 – 12:50	Chair’s intro: Where are we now? Past learnings and future perspectives	Stuart Elborn, Queen’s University (UK)
12:50 – 13:15	A path for all people living with CF? Looking back to think ahead	Fred Van Goor, Head of Cystic Fibrosis Research, Vertex Pharmaceuticals (US)
13:15 - 13:55	Panel discussion: what is the next scientific frontier in the treatment of people with CF?	Stuart Elborn (UK) and Fred Van Goor (US) plus Nicoletta Pedemonte, Giannina Gaslini Institute (IT) and Patrick Harrison, University College Cork (IE)
13:55 – 14:00	Chair’s close of symposium	Stuart Elborn, Queen’s University (UK)